NRG-GY024

Open to Accrual

Return to Protocol Table

Groningen International Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) III: A Prospective Phase II Treatment Trial

Principal Investigator

Brian M. Slomovitz

Status

Open to Accrual

Date Opened To Accrual

August 31, 2021


Disease Site

Gynecologic [GY] Cervix

Phase

II

Developmental Therapeutics

No

Primary Objective

The primary objective of this study is to investigate the safety of replacing inguinofemoral lymphadenectomy by chemoradiation in early-stage vulvar cancer patients with a macrometastasis (>2mm) and/or extracapsular extension in the Sentinel Lymph Node (SLN). The secondary objective is to evaluate the short and long-term morbidity associated with the SLN procedure and chemoradiation.

Patient Population

Early stage vulvar cancer with macrometastasis and/or extracapsular extension in the SLN

Target Accrual

15

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.